The immune system comprises organs, tissues, cells and molecules, which protect the body against pathogens.
Detailed description
The biological defense system can be separated into an innate and an adaptive part. The innate immune system developed early in the phylogeny of living things. The adaptive immune system adjusts to new or modified pathogens. Both parts collaborate closely. Moreover, the immune system can destroy abnormal or defective cells of the own body.
DZIF scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have succeeded in identifying and targeting problematic pathogens in biofilms more rapidly. The biofilm adhesion
The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine “rVSV
An international research group has identified a cellular factor of the human cell that is indispensable to the replication of Human Immunodeficiency Virus (HIV-1). Scientists of the Paul-Ehrlich
Many viral diseases tend to become chronic - including infections with the HI virus. Scientists from the DZIF site Bonn-Köln and from the TU München have now identified an immune factor which is
The Zika virus, which is transmitted by the mosquito species Aedes aegypti, is currently spreading rapidly in South America, particularly in Brazil. The virus may damage unborn foetuses during
His aim is to develop a vaccine against the widespread gastric pathogenHelicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the
Patients infected with HIV have several benefits if they are treated with antiviral medication earlier than has been usual up to now: for a start, the severe AIDS-related complications occur less
Many viruses store their hereditary information in ribonucleic acid, RNA for short. Viral RNA is very similar to that of humans. However, the human immune system can differentiate between viral
The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available. At the Hamburg-Eppendorf University Medical Center (UKE), in Geneva
The DZIF Transplant Cohort, which was officially founded as an association in February 2014, has completed its preparations. The association can now begin with recruiting first patients and collecting
